Chimerix, a US biopharmaceutical company developing oral antivirals, has appointed Peter Payne as Senior Vice President of Business Development and Corporate Strategy, and Roberto Guzman as Vice President of Corporate Compliance.
Payne will oversee Chimerix's Business Development efforts as the company continues to derive additional value from its pipeline and evaluate complementary products that may further enhance its portfolio.
Guzman will have responsibility for the design, implementation and oversight of the Chimerix Compliance Programme.
Payne has significant experience in the pharmaceutical, diagnostics and contract research industries where he has held a number of management and business development positions in the US and Europe. Most recently he was a strategy consultant to Quantum Leap Healthcare and the co-founder and CEO of eXcelerate Research. Before this he was Vice President, Corporate Development at Quintiles, and held senior roles at Wellcome Research Labs, Sterling Drug and Glaxo Group Research.
Guzman will provide Chimerix with a wide range of experience in legal, regulatory affairs, and Quality Assurance/Quality Control.
Most recently he served as Corporate Regulatory Affairs Director at Smith and Nephew where he was responsible for global regulatory affairs and quality assurance. He previously held positions in Regulatory and Quality Control at Cleveland Biolabs, Inspire Pharmaceuticals, Biomerieux North America, and Novartis-Ciba Vision Division.
